Kangstem Biotech Co., Ltd.

Research Kangstem Biotech Co., Ltd. (217730.KQ) on Bullrun: market cap KRW 180.40B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker217730.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryBiotechnology
CurrencyKRW
Market capKRW 180.40B
Financial periodQ2 2026
RevenueKRW 641.99M
Net income-KRW 6.25B
Free cash flow-KRW 4.94B
Gross margin-13.9%

Valuation Snapshot

latest market cap is KRW 180.40B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 180.40B	n/a	n/a	n/a

Dividend history

About Kangstem Biotech Co., Ltd.

Kangstem Biotech Co., Ltd. a biopharmaceutical company, develops stem cell therapeutic products for rare and incurable diseases. The company's stem cell therapy products include Furestem-AD for treatment of subacute and chronic atopic dermatitis; Furestem-RA to treat rheumatoid arthritis; and Furestem-CD for treatment of active crohn's disease.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

ORIENT BIO Inc. (002630.KS) GC Corp. (005250.KS) Pharmicell Co., Ltd. (005690.KS) Kanaph Therapeutics Inc. (0082N0.KQ) Samik Pharmaceutical Company LTD. (014950.KQ) HLB Co., Ltd. (028300) Mgen Solutions Co., Ltd. (032790.KQ) Daesung Microbiological Labs. Co., Ltd. (036480.KQ) Seoulin Bioscience Co.,Ltd. (038070.KQ) Hyundai Bioscience Co., Ltd. (048410.KQ) iNtRON Biotechnology, Inc. (048530.KQ) Synergy Innovation Co., Ltd. (048870.KQ)

Frequently asked questions

What is Kangstem Biotech Co., Ltd.'s market cap?

Kangstem Biotech Co., Ltd.'s market capitalization is KRW 180.40B.